• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Oct 8;S1201-9712(20)32206-2.
doi: 10.1016/j.ijid.2020.10.003. Online ahead of print.
A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer


Carole Nagant[SUP] 1 [/SUP], Fanny Ponthieux[SUP] 2 [/SUP], Julie Smet[SUP] 2 [/SUP], Nicolas Dauby[SUP] 3 [/SUP], Virginie Doyen[SUP] 4 [/SUP], Tatiana Besse-Hammer[SUP] 5 [/SUP], David De Bels[SUP] 6 [/SUP], Evelyne Maillart[SUP] 7 [/SUP], Francis Corazza[SUP] 8 [/SUP]



Affiliations
Free PMC article

Abstract

Objectives: We aimed to explore cytokine profile in patients related to Coronavirus Disease 2019 (COVID-19) severity and to establish a predictive cytokine score to discriminate severe from non-severe cases and provide a prognosis parameter for patients that will require intensive care unit (ICU) transfer.
Methods: Serum samples of 63 patients diagnosed with SARS-CoV-2 infection were collected early after hospital admission (day 0-3). Patients were categorized in five groups based on the clinical presentation, the PaO2/FiO2 ratio and the requirement of mechanical ventilation.
Results: Three cytokines, IL-6, IL-8 and IL-10 were markedly higher in severe forms (n = 44) than in non-severe forms (n = 19) (p < 0.005). A score combining levels of these three cytokines (IL-6*IL-8*IL-10) had the highest performance to predict severity: sensitivity of 86.4% (95% CI, 72.4-94.8) and specificity of 94.7% (95% CI, 74.0-99.9) for a cutoff value of 2068 pg/mL. Elevated levels of IL-6, IL-8 and IL-10 were also found in critically ill patients. The combination of IL-6*IL-10 serum levels allowed the highest predictability for ICU transfer: AUC of 0.898 (p < 0.0001).
Conclusion: The combinatorial IL-6*IL-8*IL-10 score at presentation was highly predictive of the progression to a severe form of the disease and could contribute to improve patients triage and to adapt therapeutic strategy within clinical trials more accurately and efficiently.

Keywords: COVID-19; IL-6; disease severity; inflammatory cytokines; intensive care unit; prediction.
 
Back
Top Bottom